Sanofi is collaborating with startup miRecule to develop an RNA therapy for facioscapulohumeral muscular dystrophy. The pharmaceutical giant gets global rights to miRecule’s therapy for this type of muscular dystrophy, which has no FDA-approved treatments.
British lawmakers voted on Tuesday to allow in vitro creation of babies using the DNA of three people, making it the first country to do so. Despite backlash based on ethical and religious perspectives, this would not be an attempt at genetic modification or creating “designer babies.” The purpose of this particular procedure is purely […]
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.